Federal Register / Vol. 73, No. 187 / Thursday, September 25, 2008 / Notices 55515 

online by accessing the PACHA Web 

site, http://www.pacha.gov. 

Members of the public will have the 

opportunity to provide comments at the 

meeting. Pre-registration is required for 

public comment. Any individual who 

wishes to participate in the public 

comment session must register online at 

http://www.pacha.gov; registration for 

public comment will not be accepted by 

telephone. Public comment will be 

limited to three minutes per speaker. 

Any members of the public who wish to 

have printed material distributed to 

PACHA members for discussion at the 

meeting should submit, at a minimum, 

one copy of the materials to the 

Committee Manager, PACHA no later 

than close of business on October 14, 

2008. Contact information for the 

PACHA Committee Manager is listed 

above. 

Dated: September 19, 2008. 

Mary (Marty) McGeein, 

Executive Director, Presidential Advisory 

Council on HIV/AIDS. 

[FR Doc. E8–22580 Filed 9–24–08; 8:45 am] 

BILLING CODE 4150–28–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60-Day–08–0691] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 or send 

comments to Maryam Daneshvar, CDC 

Acting Reports Clearance Officer, 1600 

Clifton Road, MS–D74, Atlanta, GA 

30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

State Medicaid Tobacco Coverage 

Survey (OMB No. 0920–0691)— 

Reinstatement—National Center for 

Chronic Disease Prevention and Control 

(NCCDPHP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

Tobacco use remains the leading 

preventable cause of death in the United 

States despite the availability of 

evidence-based treatments for tobacco 

dependence, which include counseling 

and FDA-approved pharmacotherapies. 

To increase both the use of treatment by 

smokers attempting to quit and the 

number of smokers who quit 

successfully, the Guide to Community 

Preventive Services recommends 

reducing the out-of-pocket cost of 

effective tobacco-dependence 

treatments, and the Public Health 

Service (PHS) Clinical Practice 

Guideline supports expanded insurance 

coverage for tobacco-dependence 

treatment. 

Medicaid recipients have 

approximately 50% greater smoking 

prevalence than the overall U.S. adult 

population, and they are 

disproportionately affected by tobaccorelated disease and disability. In 2000, 

approximately 32 million low-income 

persons in the United States received 

their health insurance coverage through 

federally funded State Medicaid 

programs, and approximately 11.5 

million (36%) of these persons smoked. 

Substantial action to improve coverage 

of tobacco-dependence treatments 

through Medicaid will be needed if the 

United States is to achieve the 2010 

National Health Objective of 12% 

smoking prevalence among adults. 

The amount and type of coverage for 

tobacco-dependence treatment offered 

by Medicaid has been collected for 

1998, 2000, 2001, 2002, 2003, 2005, 

2006, and 2007. Surveys have been 

funded by the Robert Wood Johnson 

Foundation (RWJF) (1998, 2000–2003) 

and the Centers for Disease Control and 

Prevention (CDC) (2005–2007) (OMB 

No. 0920–0691, expiration date 8/31/ 

2008). The most recent analysis of these 

information collections demonstrated 

that in 2006, 39 states provided 

coverage for some FDA-approved 

medications for the general Medicaid 

population; however, only 17 states 

provided some form of coverage for 

counseling and only seven states 

covered all FDA-approved medications 

and at least one form of counseling for 

all enrollees. Some progress has been 

made in that the number of states 

offering no benefits decreased from 15 

in 2002 to eight in 2006. 

CDC plans to request reinstatement of 

OMB approval to collect similar 

information about Medicaid coverage of 

tobacco-dependence treatments during 

the years 2008–2010. Respondents will 

be Medicaid directors in all 50 states 

and the District of Columbia. To 

minimize burden, each respondent will 

receive an electronic copy of the survey 

pre-filled with the previous year’s 

results. Respondents will only be asked 

to record changes that occurred since 

the time of the previous submission. In 

addition, respondents will be asked to 

answer new questions pertaining to the 

recommendations made in the updated 

PHS clinical practice guideline issued 

in May of 2008 regarding coverage for 

combination therapies, smokeless 

tobacco use, and their familiarity with 

and use of the 2000 PHS guideline. The 

minor changes to be incorporated in the 

revised survey instrument are not 

expected to have a significant impact on 

the overall burden estimate. As in 

previous years, each respondent will 

also attach a copy of the state’s 

Medicaid coverage plan to their 

completed survey, in order to assist the 

research team with the interpretation of 

responses. 

The information to be collected will 

allow CDC to continue monitoring 

compliance with the most recent PHS 

recommendations and the progress of 

State Medicaid Programs toward the 

2010 National Health Objectives and 

Healthy People 2010 goals. 

There are no costs to respondents 

except the time to complete the survey. 

mstockstill on PROD1PC66 with NOTICES

55516 Federal Register / Vol. 73, No. 187 / Thursday, September 25, 2008 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents No. of 

respondents 

No. of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

State Medicaid Programs ................................................................................ 51 1 0.5 26 

Total .......................................................................................................... ........................ ........................ ........................ 26 

Dated: September 16, 2008. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E8–22594 Filed 9–24–08; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Office of Community Services 

AGENCY: Office of Community Services, 

ACF, DHHS. 

ACTION: Notice To Award a Program 

Expansion Supplement to the National 

Association for State Community 

Services Program (NASCSP) in 

Washington, DC. 

CFDA#: 53.570. 

Legislative Authority: Section 

678A(a)(1)(A) of the Community 

Services Block Grant (CSBG) Act of 

1981, (Pub. L. 97–35) as amended by the 

Community Opportunities, 

Accountability, and Training and 

Educational Services (COATES) Human 

Services Reauthorization Act of 1998, 

(Pub. L. 105–285) authorizes the 

Secretary of Health and Human Services 

(HHS) to use a percentage of 

appropriated funds for training, 

technical assistance, planning, 

evaluation, performance measurement, 

monitoring, assistance for States in 

carrying out corrective actions and the 

correction of programmatic deficiencies 

of eligible entities under the CSBG Act. 

Amount of Award: $125,000. 

Project Period: 9/30/2007–9/29/2010. 

Summary: 

The purpose of this supplemental 

request is for the NASCSP to further 

improve the general capacity and 

technical competency of states to 

administer the Community Services 

Block Grant (CSBG). Targeted assistance 

will be provided to states for 

improvement in the areas of state plan 

development and Results Oriented 

Management and Accountability 

(ROMA) focused monitoring. Emerging 

training and technical assistance needs 

for states and local agencies receiving 

CSBG funds will also be assessed and a 

plan will be developed for strategic 

assistance in the areas identified. 

Additionally, this supplemental aims to 

enhance the capacity of the Office of 

Community Services (OCS) to continue 

to convene its Monitoring Task Force 

(MTF) and provide updates on its 

comprehensive response to the 

Government Accountability Office’s 

report on the CSBG program. Specific 

emphasis will be placed on monitoring 

states for compliance while encouraging 

excellence 

Contact for Further Information: 

Josephine B. Robinson, Director, Office 

of Community Services, 370 L’Enfant 

Promenade, SW., Washington, DC 

20047, Telephone: 202/401–9333. 

Dated: September 16, 2008. 

Josephine B. Robinson, 

Director, OCS. 

[FR Doc. E8–22476 Filed 9–24–08; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2008–N–0272] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Notification of a 

Health Claim or Nutrient Content Claim 

Based on an Authoritative Statement 

of a Scientific Body 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Fax written comments on the 

collection of information by October 27, 

2008. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–6974, or e-mailed to 

baguilar@omb.eop.gov. All comments 

should be identified with the OMB 

control number 0910–0374. Also 

include the FDA docket number found 

in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: 

Jonna Capezzuto, Office of Information 

Management (HFA–710), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–796–3794. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Notification of a Health Claim or 

Nutrient Content Claim Based on an 

Authoritative Statement of a Scientific 

Body—(OMB Control Number 0910– 

0374—Extension) 

Section 403(r)(2)(G) and (r)(3)(C) of 

the Federal Food, Drug and Cosmetic 

Act (the act) (21 U.S.C. 343(r)(2)(G) and 

(r)(3)(C)), as amended by the FDA 

Modernization Act of 1997, provides 

that any person may market a food 

product whose label bears a nutrient 

content claim or a health claim that is 

based on an authoritative statement of a 

scientific body of the U.S. Government 

or the National Academy of Sciences 

(NAS). Under this section of the act, a 

person that intends to use such a claim 

must submit a notification of its 

intention to use the claim 120 days 

before it begins marketing the product 

bearing the claim. In the Federal 

Register of June 11, 1998 (63 FR 32102), 

FDA announced the availability of a 

guidance entitled ‘‘Guidance for 

Industry: Notification of a Health Claim 

or Nutrient Content Claim Based on an 

Authoritative Statement of a Scientific 

Body.’’ The guidance provides the 

agency’s interpretation of terms central 

to the submission of a notification and 

the agency’s views on the information 

that should be included in the 

notification. The agency believes that 

the guidance will enable persons to 

mstockstill on PROD1PC66 with NOTICES